Bioregenx Current Ratio Growth & History (BRGX)
Bioregenx's current ratio was 0.06 for fiscal 2025.
View full Bioregenx company overviewBioregenx annual current ratio history
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.06 | −0.02 | −27.06% |
| 2024 | 2024-12-31 | 0.08 | −0.15 | −63.82% |
| 2023 | 2023-12-31 | 0.23 | 0.22 | +2147.45% |
| 2022 | 2022-12-31 | 0.01 | −1.71 | −99.39% |
| 2021 | 2021-12-31 | 1.72 | — | — |
Bioregenx quarterly current ratio
Q4.21
Q1.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 0.05 | −0.03 | −38.63% |
| Q4 2025 | 2025-12-31 | 0.06 | −0.02 | −27.06% |
| Q3 2025 | 2025-09-30 | 0.07 | −0.04 | −34.16% |
| Q2 2025 | 2025-06-30 | 0.06 | −0.03 | −33.32% |
| Q1 2025 | 2025-03-31 | 0.08 | −0.07 | −45.79% |
| Q4 2024 | 2024-12-31 | 0.08 | −0.15 | −63.82% |
| Q3 2024 | 2024-09-30 | 0.11 | — | — |
| Q2 2024 | 2024-06-30 | 0.10 | — | — |
| Q1 2024 | 2024-03-31 | 0.14 | 0.14 | — |
| Q4 2023 | 2023-12-31 | 0.23 | — | — |
| Q1 2023 | 2023-03-31 | 0.00 | — | — |
| Q4 2021 | 2021-12-31 | 1.72 | — | — |
Bioregenx current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's current ratio decreased from 1.72 to 0.06, a change of −1.66. The latest reported quarter, Q1 2026, shows 0.05.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗